Ambrosia Biosciences
Ambrosia Biosciences is a startup headquartered in Boulder, United States, founded in 2024. It has raised at least $16.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Ambrosia Biosciences has raised at least $16.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Ambrosia Biosciences sits inside the Colorado Front Range R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boulder
- Afference
- Aidium
- Alta Resource Technologies
- Althea Technologies
- Bardo Climate
- Credible Data
- Divirod
- Elephant Energy
- FinTe
- Great Sky
- Green Steel Enviornmental
Related
- Innovation profile of Boulder
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Ambrosia Biosciences do?
Ambrosia Biosciences is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Ambrosia Biosciences raised?
At least $16.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Ambrosia Biosciences based?
Ambrosia Biosciences is headquartered in Boulder, United States.
When was Ambrosia Biosciences founded?
Ambrosia Biosciences was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.